Commentary Addressing Risks and Opportunities Through the Lifecycle of Data, Technology, Advertising and Innovation

Data Counsel

Home | Data Counsel

Join <a href="https://e.bakerlaw.com/collect/click.aspx?u=YnVwZ0JFM1VuQ04xSit2K1NqVVJPbXpKUnBKNWJVSStRZ3VTWlRtSlBkWENPNyttTGNnWWZERkQ0cHEwK0xVRFpoVTExYnVySUZRaVpISDRsY2h4NXZ4djdIdld4dDFR&amp;rh=ff00a60964813039c550de9fb24a9a876fed88ba" target="_blank" rel="noreferrer noopener">Randy Shaheen</a> and <a href="https://e.bakerlaw.com/collect/click.aspx?u=YnVwZ0JFM1VuQ04xSit2K1NqVVJPbXpKUnBKNWJVSStRZ3VTWlRtSlBkWENPNyttTGNnWWZERkQ0cHEwK0xVRG9SVEY3VTEyaXFNMFpBQ2czMmxjK1ZWODlSRzhLaDlu&amp;rh=ff00a60964813039c550de9fb24a9a876fed88ba" target="_blank" rel="noreferrer noopener">Daniel Kaufman</a> as they discuss the Federal Trade Commission’s new Health Products Compliance Guidance. During this webinar, they will share their insights about the new Guidance, highlight areas of particular importance for anyone involved in marketing or analyzing health claims, and explain how this new document differs from the agency’s two-decade-old Dietary Supplement Guidance. This session is the third event in our monthly 2023 Advertising CLE Webinar Showcase. The program is approved for 1.0 hour of CLE credit.

core/paragraph

<a href="https://www.bakerlaw.com/events/2023-advertising-cle-webinar-showcase"><u>Read more</u></a>.

The Federal Trade Commission’s New Health Product Compliance Guidance